Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
Vaubel, Rachael A. , Tian, Shulan , Remonde, Dioval , Mladek, Ann C. , Kitange, Gaspar J. , Caron, Alissa, Kollmeyer, Thomas M. , Grove, Rebecca, Peng, Sen, Carlson, Brett L. , Sarkar, Gobinda , Evers, Lisa, Decker, Paul A. , Yan, Huihuang , Berens, Michael E. , Wang, Qianghu , Marin, Bianca M. , Klee, Eric W. , Eckel‐Passow, Jeanette E. , Verhaak, Roel G.W. , Sulman, Erik P. , Meyer, Fredrick B., Tran, Nhan L. , Jenkins, Robert B. , Schroeder, Mark A. , Sarkar, Gobinda , Berens, Michael E , Wang, Qianghu , Marin, Bianca M , Califano, Andrea , Sulman, Erik P , O'Neill, Brian P, Parney, Ian F , Kollmeyer, Thomas , Vaubel, Rachael A , Mladek, Ann C , Tran, Nhan L , Grove, Rebecca, Daniel, J. , Decker, Paul A. , Dhruv, Harshil , Lachance, Daniel Honore , Burns, Terry C. , O’Neill, Brian Patrick , Giannini, Caterina , Parney, Ian F. , Sarkaria, Jann N.

Mayo Clinic

Clinical Cancer Research | December 18, 2019 | Volume: 26 | Issue: 5 | Pages: 1094-1104

10.1158/1078-0432.ccr-19-0909 | PMID 31852831 Get It

Abstract Purpose: Glioblastoma is the most frequent and lethal primary brain tumor. Development of novel therapies relies on the availability of relevant preclinical models. We have established a panel of 96 glioblastoma patient-derived xenografts (PDX) and undertaken its genomic and phenotypic characterization. Experimental Design: PDXs were established from glioblastoma, IDH-wildtype (n = 93), glioblastoma, IDH-mutant (n = 2), diffuse midline glioma, H3 K27M-mutant (n = 1), and both primary (n = 60) and recurrent (n = 34) tumors. Tumor growth rates, histopathology, and treatment response were characterized. Integrated molecular profiling was performed by whole-exome sequencing (WES, n = 83), RNA-sequencing (n = 68), and genome-wide methylation profiling (n = 76). WES data from 24 patient tumors was compared with derivative models. Results: PDXs recapitulate many key phenotypic and molecular features of patient tumors. Orthotopic PDXs show characteristic tumor morphology and invasion patterns, but largely lack microvascular proliferation and necrosis. PDXs capture common and rare molecular drivers, including alterations of TERT, EGFR, PTEN, TP53, BRAF, and IDH1, most at frequencies comparable with human glioblastoma. However, PDGFRA amplification was absent. RNA-sequencing and genome-wide methylation profiling demonstrated broad representation of glioblastoma molecular subtypes. MGMT promoter methylation correlated with increased survival in response to temozolomide. WES of 24 matched patient tumors showed preservation of most genetic driver alterations, including EGFR amplification. However, in four patient–PDX pairs, driver alterations were gained or lost on engraftment, consistent with clonal selection. Conclusions: Our PDX panel captures the molecular heterogeneity of glioblastoma and recapitulates many salient genetic and phenotypic features. All models and genomic data are openly available to investigators.
Letter: the gluten‐free diet as a bottom‐up approach for irritable bowel syndrome. Authors' reply
Tuck, Caroline J. , Vanner, Stephen , Camilleri, Michael , Tuck, Caroline , Jing Wang, Xiao, Wang, Xiao‐Jing

Mayo Clinic

Alimentary Pharmacology & Therapeutics | December 18, 2019 | Volume: 51 | Issue: 1 | Pages: 185-186

10.1111/apt.15560 | PMID 31850581 Get It

LINKED CONTENTThis article is linked to Wang et al and Rej et al papers. To view these articles, visit https://doi.org/10.1111/apt.15419 and https://doi.org/10.1111/apt.15517.
Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis
Yousufuddin, Mohammed , Major, Brittny , Ahmmad, Eimad M. , Alzu’bi, Hossam , Peters, Jessica , Doyle, Taylor, Ward, Ruaa Y. Al, Seshadri, Ashok , Simha, Vinaya , Murad, M. Hassan , Al-Ward, Ruaa , Takahashi, Paul Y. , Ahmmad, Eimad, Al-Zubi, Hossam, Al Ward, Ruaa Y, Murad, M Hassan , Peters, Jessica, Jensen, Kelsey , Sharma, Umesh, Wang, Zhen

Mayo Clinic

BMJ Open | December 16, 2019 | Volume: 9 | Issue: 12 | Pages: e028638

10.1136/bmjopen-2018-028638 | PMID 31843818 Get It

Objective To examine the effect of HLP, defined as having a pre-existing or a new in-hospital diagnosis based on low density lipoprotein cholesterol (LDL-C) level ≥100 mg/dL during index hospitalisation or within the preceding 6 months, on all-cause mortality after hospitalisation for acute myocardial infarction (AMI) or acute decompensated heart failure (ADHF) and to determine whether HLP modifies mortality associations of other competing comorbidities. A systematic review and meta-analysis to place the current findings in the context of published literature. Design Retrospective study, 1:1 propensity-score matching cohorts; a meta-analysis. Setting Large academic centre, 1996–2015. Participants Hospitalised patients with AMI or ADHF. Main outcomes and measures All-cause mortality and meta-analysis of relative risks (RR). Results Unmatched cohorts: 13 680 patients with AMI (age (mean) 68.5 ± (SD) 13.7 years; 7894 (58%) with HLP) and 9717 patients with ADHF (age, 73.1±13.7 years; 3668 (38%) with HLP). In matched cohorts, the mortality was lower in AMI patients (n=4348 pairs) with HLP versus no HLP, 5.9 versus 8.6/100 person-years of follow-up, respectively (HR 0.76, 95% CI 0.72 to 0.80). A similar mortality reduction occurred in matched ADHF patients (n=2879 pairs) with or without HLP (12.4 vs 16.3 deaths/100 person-years; HR 0.80, 95% CI 0.75 to 0.86). HRs showed modest reductions when HLP occurred concurrently with other comorbidities. Meta-analyses of nine observational studies showed that HLP was associated with a lower mortality at ≥2 years after incident AMI or ADHF (AMI: RR 0.72, 95% CI 0.69 to 0.76; heart failure (HF): RR 0.67, 95% CI 0.55 to 0.81). Conclusions Among matched AMI and ADHF cohorts, concurrent HLP, compared with no HLP, was associated with a lower mortality and attenuation of mortality associations with other competing comorbidities. These findings were supported by a systematic review and meta-analysis.
Use of Bone-Modifying Agents Among Medicare Beneficiaries With Multiple Myeloma
Wang, Peiqi , Ali, Syed Abbas , Overton, Heidi N., Makary, Martin A. , Kochenderfer, James N. , Gupta, Arjun , Rajkumar, S. Vincent , Gyawali, Bishal

Mayo Clinic

JAMA Oncology | December 12, 2019 | Volume: 6 | Issue: 2 | Pages: 296

10.1001/jamaoncol.2019.5426 | PMID 31830210 Get It

Linkage Mapping for Foliar Necrosis of Soybean Sudden Death Syndrome
Chang, Hao‐Xun , Wen, Zixiang, Tan, Ruijuan, Dong, Hongxu , Wickland, Daniel P. , Wang, Dechun , Chilvers, Martin I.

Mayo Clinic

Phytopathology® | December 10, 2019 | Volume: 110 | Issue: 4 | Pages: 907-915

10.1094/phyto-09-19-0330-r | PMID 31821112 Get It

Sudden death syndrome (SDS) foliar symptoms consist of foliar chlorosis, foliar necrosis, leaf marginal curling, and premature defoliation, but resistance screening has been evaluated mostly based on the overall SDS foliar severity rather than on a specific foliar symptom. This study generated an F2 population derived from crossing the susceptible variety Sloan and the resistant germplasm line PI 243518, which exhibits resistance to both foliar chlorosis and necrosis. A total of 400 F2 lines were evaluated for foliar chlorosis, foliar necrosis, and overall SDS foliar symptoms, separately. Genotyping-by-sequencing was applied to obtain single nucleotide polymorphisms (SNPs) in the F2 population, and linkage mapping using 135 F2 lines with 969 high-quality SNPs identified a locus on chromosome 13 for foliar necrosis and SDS foliar symptoms. The locus partially overlaps with loci previously reported for SDS on chromosome 13, which is the third time the region from 15.98 to 21.00 Mbp has been reproduced independently and therefore qualifies this locus for a new nomenclature proposed as Rfv13-02. In summary, this study generated a new biparental population that enables not only the discovery of a locus for foliar necrosis and SDS foliar symptoms on chromosome 13 but also the potential for advanced exploration of SDS foliar resistance derived from the germplasm line PI 243518.
Predictors of nonroutine discharge among patients undergoing surgery for grade I spondylolisthesis: insights from the Quality Outcomes Database
Mummaneni, Praveen V. , Bydon, Mohamad , Knightly, John J. , Alvi, Mohammed Ali , Chan, Andrew K. , Biase, Michael, Strauss, Andrea, Glassman, Steven D. , Foley, Kevin T. , Slotkin, Jonathan R., Potts, Eric A. , Shaffrey, Mark E., Shaffrey, Christopher I. , Haid, Regis W., Fu, Kai-Ming, Wang, Michael Y. , Park, Paul , Asher, Anthony L. , Bisson, Erica F. , Alvi, Mohammed Ali , Goyal, Anshit , Guan, Jian , Strauss, Andrea

Mayo Clinic

Journal of Neurosurgery: Spine | December 6, 2019 | Volume: 32 | Issue: 4 | Pages: 523-532

10.3171/2019.9.spine19644 | PMID 31812142 Get It

OBJECTIVEDischarge to an inpatient rehabilitation facility or another acute-care facility not only constitutes a postoperative challenge for patients and their care team but also contributes significantly to healthcare costs. In this era of changing dynamics of healthcare payment models in which cost overruns are being increasingly shifted to surgeons and hospitals, it is important to better understand outcomes such as discharge disposition. In the current article, the authors sought to develop a predictive model for factors associated with nonroutine discharge after surgery for grade I spondylolisthesis.METHODSThe authors queried the Quality Outcomes Database for patients with grade I lumbar degenerative spondylolisthesis who underwent a surgical intervention between July 2014 and June 2016. Only those patients enrolled in a multisite study investigating the impact of fusion on clinical and patient-reported outcomes among patients with grade I spondylolisthesis were evaluated. Nonroutine discharge was defined as those who were discharged to a postacute or nonacute-care setting in the same hospital or transferred to another acute-care facility.RESULTSOf the 608 patients eligible for inclusion, 9.4% (n = 57) had a nonroutine discharge (8.7%, n = 53 discharged to inpatient postacute or nonacute care in the same hospital and 0.7%, n = 4 transferred to another acute-care facility). Compared to patients who were discharged to home, patients who had a nonroutine discharge were more likely to have diabetes (26.3%, n = 15 vs 15.7%, n = 86, p = 0.039); impaired ambulation (26.3%, n = 15 vs 10.2%, n = 56, p < 0.001); higher Oswestry Disability Index at baseline (51 [IQR 42–62.12] vs 46 [IQR 34.4–58], p = 0.014); lower EuroQol-5D scores (0.437 [IQR 0.308–0.708] vs 0.597 [IQR 0.358–0.708], p = 0.010); higher American Society of Anesthesiologists score (3 or 4: 63.2%, n = 36 vs 36.7%, n = 201, p = 0.002); and longer length of stay (4 days [IQR 3–5] vs 2 days [IQR 1–3], p < 0.001); and were more likely to suffer a complication (14%, n = 8 vs 5.6%, n = 31, p = 0.014). On multivariable logistic regression, factors found to be independently associated with higher odds of nonroutine discharge included older age (interquartile OR 9.14, 95% CI 3.79–22.1, p < 0.001), higher body mass index (interquartile OR 2.04, 95% CI 1.31–3.25, p < 0.001), presence of depression (OR 4.28, 95% CI 1.96–9.35, p < 0.001), fusion surgery compared with decompression alone (OR 1.3, 95% CI 1.1–1.6, p < 0.001), and any complication (OR 3.9, 95% CI 1.4–10.9, p < 0.001).CONCLUSIONSIn this multisite study of a defined cohort of patients undergoing surgery for grade I spondylolisthesis, factors associated with higher odds of nonroutine discharge included older age, higher body mass index, presence of depression, and occurrence of any complication.
Implementation of a Global Quality Improvement Project in 20 Countries: A Case Study
Coville, Hongchuan , Wang, Bo , Sabov, Moldovan, Yi, Lisha, Suzuki, Reina , Lei, Fan, Gavrilović, Srdjan , Hache, Manuel, Barwise, Amelia , Kashyap, Rahul , Vukoja, Marija , Gajic, Ognjen , Dong, Yue

Mayo Clinic

No container title available | December 5, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.18327/v1 Get It

Abstract Background: The Checklist for Early Recognition and Treatment of Acute Illness and Injury (CERTAIN) study is a before-and-after clinical quality improvement study involving 20 countries. Our aim was to describe the challenges and solutions for study implementation across various intensive care units.Methods: After local institutional review board approval, each study center had a setup period before patient data were collected. Each center was required to accomplish 4 stages: baseline data collection, remote simulation training, local implementation, and postimplementation data collection and maintenance of process of care. We measured the time required to complete each study stage and used the Define, Measure, Analyze, Improve, and Control (DMAIC) framework to identify the challenges encountered during each stage and guide improvement strategies to facilitate implementation of CERTAIN.Results: Between June 2012 and December 2017, 55 centers from 20 countries were recruited to participate. The time to complete each stage at different centers varied significantly. The most common domains in which challenges occurred were 1) leadership support and team building, 2) communication, 3) work environment culture, 4) language barriers, 5) infrastructure and technology, and 6) sustainability. Obstacles in these 6 areas delayed reaching major milestones of the study. Different strategies were deployed to overcome these barriers: engaging leadership for support, using native-speaking clinicians during training sessions, using various communication platforms, providing personal computers to local hospitals, making in-person site visits, offering flexible training time, and supporting local centers’ grant applications. Centers that enrolled during the control phase, compared with those that enrolled earlier, had significantly shorter times and less variation in times for each study stage and for the total study time.Conclusions: By using the DMAIC method, we identified the predominant 6 domains in which challenges occurred during implementation of the global CERTAIN study and developed targeted strategies to overcome the challenges and shorten the duration of the study. The DMAIC method would be useful in improving the efficiency of other large-scale multinational quality improvement projects.
Nonlinear Z‐score modeling for improved detection of cognitive abnormality
Kornak, John , Fields, Julie A. , Kremers, Walter K. , Farmer, Sara A., Heuer, Hilary W. , Forsberg, Leah K. , Brushaber, Danielle , Rindels, Amy, Weıntraub, Sandra , Besser, Lilah M., Bordelon, Yvette , Bove, Jessica, Brannelly, Patrick , Caso, Christina, Coppola, Giovanni , Dever, Reilly, Dheel, Christina, Dickerson, Bradford, Dickinson, Susan, Domínguez, S. Carbajal, Domoto‐Reilly, Kimiko , Faber, Kelley , Ferrall, Jessica, Fishman, Ann, Gavrilova, Ralitza H. , Gearhart, Deb, Ghazanfari, Behnaz, Ghoshal, Nupur , Graff‐Radford, Jonathan , Graff‐Radford, Neill R. , Grant, Ian , Haley, Dana , Hsiao, John , Hsiung, Ging‐Yuek Robin , Huey, Edward D. , Irwin, David J. , Jones, Lynne C. , Kantarci, Kejal , Karydas, Anna, Kaufer, Daniel , Kraft, Ruth, Kramer, Joel H. , Kukull, Walter A. , Ljubenkov, Peter A. , Lucente, Diane , Lungu, Codrin , Mackenzie, Ian R. , Maldonado, Miranda, Manoochehri, Masood , McGinnis, Scott, McKinley, Emily , Mendez, Mario F. , Miller, Bruce L. , Multani, Namita, Onyike, Chiadi U. , Pantelyat, Alexander , Pearlman, Rodney , Petrucelli, Len, Potter, Madeline, Rademakers, Rosa , Ramos, Eliana Marisa , Rankin, Katherine P. , Rascovsky, Katya, Roberson, Erik D. , Rogalski-Miller, Emily, Sengdy, Pheth, Shaw, Les, Staffaroni, Adam M. , Sutherland, Margaret , Syrjanen, Jeremy A. , Tartaglia, Maria Carmela , Tatton, Nadine , Taylor, Joanne, Trojanowski, John Q. , Wong, Bonnie , Boxer, Adam L. , Rosen, Howard J. , Farmer, Sara, Irwin, David J , Hsiung, Gink-Yuek , Roberson, Erik , Miller, Bruce L , Kantarci, Kejal , Pantelyat, Alex , Tartaglia, Maria Carmela , Kremers, Walter K , Domoto-Reilly, Kimiko , Dodge, Hiroko Hayama , Appleby, Brian S. , Fong, Jamie , Foroud, Tatiana , Gearhart, Deb, Goldman, Jill , Grossman, Murray , Jones, David T. , Jones, Lynne, Kerwin, Diana , Knopman, David S. , Lapid, Maria I. , Litvan, Irene , Padmanabhan, Jaya , Toga, Arthur W. , Wang, Ping , Wszołek, Zbigniew K. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | December 5, 2019 | Volume: 11 | Issue: 1 | Pages: 797-808

10.1016/j.dadm.2019.08.003 | PMID 31872042 Get It

AbstractIntroductionConventional Z‐scores are generated by subtracting the mean and dividing by the standard deviation. More recent methods linearly correct for age, sex, and education, so that these “adjusted” Z‐scores better represent whether an individual's cognitive performance is abnormal. Extreme negative Z‐scores for individuals relative to this normative distribution are considered indicative of cognitive deficiency.MethodsIn this article, we consider nonlinear shape constrained additive models accounting for age, sex, and education (correcting for nonlinearity). Additional shape constrained additive models account for varying standard deviation of the cognitive scores with age (correcting for heterogeneity of variance).ResultsCorrected Z‐scores based on nonlinear shape constrained additive models provide improved adjustment for age, sex, and education, as indicated by higher adjusted‐R2.DiscussionNonlinearly corrected Z‐scores with respect to age, sex, and education with age‐varying residual standard deviation allow for improved detection of non‐normative extreme cognitive scores.
Integrative Omics Approach to Identifying Genes Associated With Atrial Fibrillation
Wang, Biqi , Lunetta, Kathryn L. , Lubitz, Steven A. , Trinquart, Ludovic , Yao, Lixia , Benjamin, Emelia J. , Benjamin, Emelia J , Lubitz, Steven A , Dupuis, Josée , Ellinor, Patrick T. , Lin, Honghuang

Mayo Clinic

Circulation Research | December 5, 2019 | Volume: 126 | Issue: 3 | Pages: 350-360

10.1161/circresaha.119.315179 | PMID 31801406 Get It

Rationale: GWAS (Genome-Wide Association Studies) have identified hundreds of genetic loci associated with atrial fibrillation (AF). However, these loci explain only a small proportion of AF heritability. Objective: To develop an approach to identify additional AF-related genes by integrating multiple omics data. Methods and Results: Three types of omics data were integrated: (1) summary statistics from the AFGen 2017 GWAS; (2) a whole blood EWAS (Epigenome-Wide Association Study) of AF; and (3) a whole blood TWAS (Transcriptome-Wide Association Study) of AF. The variant-level GWAS results were collapsed into gene-level associations using fast set-based association analysis. The CpG-level EWAS results were also collapsed into gene-level associations by an adapted SNP-set Kernel Association Test approach. Both GWAS and EWAS gene-based associations were then meta-analyzed with TWAS using a fixed-effects model weighted by the sample size of each data set. A tissue-specific network was subsequently constructed using the NetWAS (Network-Wide Association Study). The identified genes were then compared with the AFGen 2018 GWAS that contained more than triple the number of AF cases compared with AFGen 2017 GWAS. We observed that the multiomics approach identified many more relevant AF-related genes than using AFGen 2018 GWAS alone (1931 versus 206 genes). Many of these genes are involved in the development and regulation of heart- and muscle-related biological processes. Moreover, the gene set identified by multiomics approach explained much more AF variance than those identified by GWAS alone (10.4% versus 3.5%). Conclusions: We developed a strategy to integrate multiple omics data to identify AF-related genes. Our integrative approach may be useful to improve the power of traditional GWAS, which might be particularly useful for rare traits and diseases with limited sample size.
International consensus statements for endoscopic management of distal biliary stricture
Nakai, Yousuke , Rerknimitr, Rungsun , Khor, Christopher , Yasuda, Ichiro , Lau, James Y. , Lakhtakia, Sundeep , Ratanachu‐ek, Thawee , Lee, Dong Ki , Makmun, Dadang , Dy, Frederick, Draganov, Peter V. , Almadi, Majid A. , Ryozawa, Shomei , Wallace, Michael B. , Itoi, Takao , Devereaux, Benedict , Aniwan, Satimai , Makmun, Dadang , Rerknimitr, Rungsun , Yasuda, Ichiro , Lau, James , Lakhtakia, Sundeep , Kitano, Masayuki , Devereaux, Benedict , Wallace, Michael B , Isayama, Hiroyuki , Wang, Hsiu‐Po , Kogure, Hirofumi , Moon, Jong Ho , Seo, Dong Wan , Liao, Wei‐Chih , Irisawa, Atsushi , Katanuma, Akio , Fujisawa, Toshio

Mayo Clinic

Journal of Gastroenterology and Hepatology | December 5, 2019 | Volume: 35 | Issue: 6 | Pages: 967-979

10.1111/jgh.14955 | PMID 31802537 Get It

AbstractDistal biliary strictures (DBS) are common and may be caused by both malignant and benign pathologies. While endoscopic procedures play a major role in their management, a comprehensive review of the subject is still lacking. Our consensus statements were formulated by a group of expert Asian pancreatico‐biliary interventional endoscopists, following a proposal from the Digestive Endoscopy Society of Taiwan, the Thai Association for Gastrointestinal Endoscopy, and the Tokyo Conference of Asian Pancreato‐biliary Interventional Endoscopy. Based on a literature review utilizing Medline, Cochrane library, and Embase databases, a total of 19 consensus statements on DBS were made on diagnosis, endoscopic drainage, benign biliary stricture, malignant biliary stricture, and management of recurrent biliary obstruction and other complications. Our consensus statements provide comprehensive guidance for the endoscopic management of DBS.